Cytologic Diagnosis of Malignant Pleural Effusion in Multiple Myeloma - Two Case Reports -
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Malignant pleural effusion in multiple myeloma (MM) is extremely rare and is associated with poor prognosis. We experienced two cases of MM IgA type with malignant pleural effusion. The diagnoses were based on characteristic cytology and CD138 immunocytochemistry. The patients received several cycles of combination chemotherapy, since symptoms were more aggressive with an uncontrolled pleural effusion. We review the clinical features of these cases and literature concerning myelomatous pleural effusion.
Abstract
Malignant pleural effusion in multiple myeloma (MM) is extremely rare and is associated with poor prognosis. We experienced two cases of MM IgA type with malignant pleural effusion. The diagnoses were based on characteristic cytology and CD138 immunocytochemistry. The patients received several cycles of combination chemotherapy, since symptoms were more aggressive with an uncontrolled pleural effusion. We review the clinical features of these cases and literature concerning myelomatous pleural effusion.
참고문헌 (13)
- Palmer HE, "Cytology and flow cytometry of malignant effusions of multiple myeloma", Diagn Cytopathol, 22, pp.147~151 (2000)
- Ghosh S, "Myelomatous pleural effusion", J Assoc Physicians India, 54, pp.738~739 (2006)
- Alexandrakis MG, "Pleural effusions in hematologic malignancies", Chest, 125, pp.1546~1555 (2004)
- Kamble R, "Malignant pleural effusion of multiple myeloma: prognostic factors and outcome", Leuk Lymphoma, 46, pp.1137~1142 (2005)
- Kapadia SB, "Cytological diagnosis of malignant pleural effusion in myeloma", Arch Pathol Lab Med, 101, pp.534~535 (1977)
- Chilosi M, "CD138", syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies, 1999, pp.12, 1101~1106
- Van Camp B, "Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1;Leu-19)", Blood, 76, pp.377~382 (1990)
- Pellat-Deceunynck C, "The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma", Leukemia, 12, pp.1977~1982 (1998)
- Dahl IM, "Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma", Br J Haematol, 116, pp.273~277 (2002)
- Chang H, "Myelomatous pleural effusion in a patient with plasmablastic myeloma: a case report", Diagn Cytopathol, 37, pp.205~207 (2009)
- Lau LG, "Malignant pleural effusion in a patient with multiple myeloma", Diagn Cytopathol, 32, pp.171~172 (2005)
- Chang H, "Prognostic relevance of CD56 expression in multiple myeloma: a study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant", Leuk Lymphoma, 47, pp.43~47 (2006)
- Sahara N, "Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma", Br J Haematol, 117, pp.882~885 (2002)